Product
Recombinant Von Willebrand factor
1 clinical trial
2 indications
Indication
Von Willebrand DiseaseIndication
Postpartum HemorrhageClinical trial
Prospective, Randomized Trial Comparing Recombinant Von Willebrand Factor (rVWF) Plus Tranexamic Acid vs. rVWF Alone to Reduce Postpartum Hemorrhage in Women With Von Willebrand Disease: The VWD-WOMAN TrialStatus: Recruiting, Estimated PCD: 2024-08-01